A61K 40/4262
Heat shock proteins
Official title: {Heat shock proteins}
A61K40/4262 (Heat shock proteins) appears on 54 US grants and 63 published applications in this corpus.
Search patents in A61K- Granted patents
- 54
- Published applications
- 63
- Assignees
- 45
- Inventors
- 107
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 15 | 3 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 4 |
| 2007 | 0 | 1 |
| 2008 | 2 | 6 |
| 2009 | 3 | 2 |
| 2010 | 1 | 3 |
| 2011 | 2 | 1 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 4 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 4 | 6 |
| 2021 | 0 | 3 |
| 2022 | 2 | 6 |
| 2023 | 3 | 3 |
| 2024 | 4 | 2 |
| 2025 | 2 | 2 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- GRP78 targeted adoptive cell therapy16 Jun 2026US 12,655,192 B2St. Jude Children?S Research Hospital
- Preparation of a therapeutic composition for treating autoimmune diseases31 Mar 2026US 12,589,113 B2Avotres, Inc.
- HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell21 Oct 2025US 12,448,413 B2NEC Corporation
- Vaccine compositions and methods25 Feb 2025US 12,233,091 B2Mirror Biologics, Inc.
- Method for treating multiple sclerosis with peptide-loaded dendritic cells3 Sep 2024US 12,076,345 B2Avotres, Inc.
- Tuned car10 Jul 2025US 2025/0222025 A1Oslo Universitetssykehus Hf
- Preparation of a therapeutic composition for treating autoimmune diseases16 Jan 2025US 2025/0017972 A1Avotres, Inc.
- Preparation and application of chimeric antigen receptor immune cell constructed on basis of granzyme b29 Aug 2024US 2024/0285686 A1West China Hospital, Sichuan University
- Preparation and application of chimeric antigen receptor immune cell constructed on basis of lox122 Aug 2024US 2024/0277769 A1West China Hospital, Sichuan University
- Grp78 targeted adoptive cell therapy5 Oct 2023US 2023/0312671 A1St. Jude Children's Research Hospital
Most cited
By later US patents
- Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy109US 5,830,464 AFordham University · 1998
- Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes92US 5,985,270 AFordham University · 1999
- Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes64US 6,017,540 AFordham University · 2000
- Treatment of primary and metastatic neoplastic diseases with HSP70-peptide complexes57US 6,403,095 B1Fordham University · 2002
- Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation52US 7,557,200 B2The Johns Hopkins University · 2009